-+ 0.00%
-+ 0.00%
-+ 0.00%

PRESS RELEASE: SANOFI’S LUNSEKIMIG MET PRIMARY AND KEY SECONDARY ENDPOINTS IN PHASE 2 RESPIRATORY STUDIES IN ASTHMA AND CRSWNP

Reuters·04/07/2026 05:00:00

Please log in to view news